Table 3.
The results of laboratory tests and instrumental examinations of patients at the time of inclusion with the study.
| Parameters | Total cohort (n=1003) | AF-HFpEF (n=387) | AF-HFmEF EF (n=150) | AF-HFrEF (n=466) | p level |
|---|---|---|---|---|---|
| Left ventricular ejection fraction, % | 40 (35 : 58) | 60 (55 : 65) | 43 (40 : 46) | 34 (29 : 37) | <0.0001 |
| Aortic insufficiency | 410 (50.9%) | 166 (42.9%) | 57 (38%) | 187 (40.1%) | 0.529 |
| Mitral insufficiency | 805 (80.3%) | 310 (80.1%) | 123 (82%) | 372 (79.8%) | 0.841 |
| Pulmonary insufficiency | 367 (36.6%) | 135 (34.9%) | 52 (34.7%) | 180 (38.6%) | 0.459 |
| Tricuspidal insufficiency | 766 (76.4%) | 284 (73.4%) | 121 (80.7%) | 361 (77.5%) | 0.153 |
| Left ventricular end diastolic dimension, cm | 5.6 (5 : 6.3) | 5 (4.6 : 5.3) | 5.9 (5.3 : 6.38) | 6.2 (5.7 : 6.91) | <0.0001 |
| Left ventricular end systolic dimension, cm | 4.1 (3.2 : 5.05) | 3.1 (3 : 3.6) | 4.5 (4 : 5) | 5 (4.5 : 5.7) | <0.0001 |
| Cardiothoracic index (%) | 57 (54 : 62) | 56.5 (53 : 61) | 60 (55 : 63) | 57 (55 : 63) | 0.086 |
| Ventricular extrasystoles, total | 122 (17 : 775.5) | 40 (8 : 327.25) | 79 (13 : 1163) | 277 (78.5 : 1319) | 0.029 |
| Laboratory analysis | |||||
| BNP | 300 (158.25 : 602.48) | 245.5 (152.25 : 429.75) | 317.5 (142.25 : 507.15) | 490.5 (186.52 : 941.75) | 0.008 |
| NT-proBNР | 536 (349.5 : 1085) | 562 (425 : 968) | 338 (327 : 353.5) | 1484 (289 : 2866) | 0.01 |
| International normalised ratio | 1.27 (1.04 : 2) | 1.15 (1 : 1.67) | 1.29 (1.1 : 1.9) | 1.42 (1.1 : 2.08) | 0.019 |
| D-dimer | 1.2 (0.35 : 4.75) | 1.38 (0.22 : 109) | 2 (0.24 : 187) | 1.1 (0.49 : 1.65) | 0.048 |